http://www.adamaspharma.com
Adamas Pharmaceuticals, Inc. Company Intro
Adamas Pharmaceuticals makes everyday life significantly better for people affected by neurological diseases.
Industry
Healthcare
Adamas Pharmaceuticals, Inc. Headquaters
1900 Powell Street
EmeryVille,94608
United States
Adamas Pharmaceuticals, Inc. Share price
22 Oct 2020 01:01 GMT
$3.8700
-0.03 (-0.77 %)
Adamas Pharmaceuticals, Inc. Market cap
$105.491 M
WMC RANKING
2020
Adamas Pharmaceuticals, Inc. # 34
Drug Manufacturers—Specialty & GenericLatest Adamas Pharmaceuticals, Inc. News
21 Oct 2020
Parkinson's Disease Drugs Market Research by 2020 – Top ...
Inc. Impax Laboratories Inc. AbbVie Inc. Mylan NV; Boehringer Ingelheim ... For instance, Adamas Pharmaceuticals' amantadine extended-release capsules ...
21 Oct 2020
Global Parkinson's Disease Drugs Market 2020: Top Leading Countries, Companies, Consumption, Drivers, Trends, Marketed and Phase III Drugs Landscape
For instance, Adamas Pharmaceuticals' amantadine extended-release ... M Somerset Pharmaceuticals Inc. Teva Pharmaceuticals Industries Ltd; Pfizer Inc.
21 Oct 2020
Not Throwing In The Towel: Gulfport Energy Corporation (GPOR), Adamas Pharmaceuticals Inc. (ADMS)
Adamas Pharmaceuticals Inc. (ADMS) shares on Tuesday's trading session, dropped -8.67 percent to see the stock exchange hands at $3.90 per unit.
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Adamas Pharmaceuticals, Inc. | 0.38 | 0.31 | 22.58 | 0 | 0 | 0 | 8.46 |
| Teva Pharmaceutical Industries Limited | 100 | 65.10 | 45.16 | 54 | 0 | 0 | 60.80 |
| Bausch Health Companies Inc. | 48.30 | 17.02 | 0 | 64 | 0 | 0 | 29.89 |
| Zoetis Inc. | 37.77 | 100 | 90.32 | 80 | 0 | 0 | 100 |
| Perrigo Company plc | 28.05 | 9.83 | 100 | 100 | 0 | 0 | 77.56 |
Adamas Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Adamas Pharmaceuticals, Inc. | $63,556 | $125,431 | $-77,871 | $110.299M | 34 |
| Teva Pharmaceutical Industries Limited | $16,788,000 | $4,571,000 | $4,000 | $10.171B | 1 |
| Bausch Health Companies Inc. | $8,109,000 | $4,775,000 | $-2,043,000 | $6.054B | 2 |
| Zoetis Inc. | $6,340,000 | $2,265,000 | $1,617,000 | $75.876B | 3 |
| Perrigo Company plc | $4,709,800 | $1,348,000 | $246,500 | $6.3B | 4 |